Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Simple Non-Invasive Hair-Based Test Could Speed ALS Diagnosis

By LabMedica International staff writers
Posted on 08 Sep 2025

Amyotrophic lateral sclerosis (ALS) is a progressive and fatal neurodegenerative disease that often takes more than a year to diagnose after symptoms appear. More...

Early detection is critical, as it can improve quality of life and potentially prolong survival, but current biomarkers are invasive, expensive, and difficult to integrate into routine care. Researchers have now shown that a single strand of hair can reveal unique elemental patterns that distinguish ALS patients from healthy individuals. This paves the way for a simple, non-invasive hair-based test to speed ALS diagnosis and improve patient care.

In a study led by the Icahn School of Medicine at Mount Sinai (New York City, NY, USA), researchers used advanced laser ablation-inductively coupled plasma-mass spectrometry to analyze single hair strands. This technique vaporizes tiny particles to measure elemental and isotopic composition, providing up to 800 time points of data per strand at two- to four-hour intervals. The investigators assessed 17 elements, including copper, zinc, magnesium, and lead, and applied information-theory tools to map how patterns shifted over time.

The analysis included 391 people, 295 with ALS and 96 healthy controls, with hair samples collected from both a regional ALS center and nationwide. Results showed patients with ALS had significantly lower synchrony in copper-based elemental networks, suggesting systemic dysregulation in copper metabolism. The findings, published in eBioMedicine, revealed sex-specific differences, with men showing weaker copper-zinc dynamics and women showing disruptions in chromium-nickel patterns.

The study provides proof-of-concept that hair could serve as a non-invasive, scalable biomarker for ALS. A hair-based test might help shorten the time to diagnosis, enabling patients to access medications, nutritional plans, therapy, and assistive devices earlier. Researchers stress that while not yet a diagnostic test, the approach could transform care by making ALS detection faster, easier, and more accessible, with future work needed to refine and validate its use in clinical practice.

“Our study demonstrates that hair can serve as a window into the body’s elemental balance,” said Manish Arora, BDS, MPH, PhD, senior author of the study. “By analyzing the biodynamics of elements such as copper over time, we can detect disruptions associated with ALS in a simple, non-invasive way. This approach has the potential to transform how we diagnose ALS, making it faster, easier, and more accessible for patients.”

Related Links:
Icahn School of Medicine


Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Collection and Transport System
PurSafe Plus®
New
Sample Transportation System
Tempus1800 Necto
New
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.